Featured News
- Innovate
- Investigate
- Educate
Fellows 2018
Educational Grant Support
Educational Grant Support
The 24th Annual Interventional Cardiology Fellows Course is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from commercial supporters.
The educational grant support of our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated to educating medical professionals and the public to improve patient outcomes, helps to make this program possible.
The Cardiovascular Research Foundation gratefully acknowledges the educational grant support for the 24th Annual Interventional Cardiology Fellows Course:
MAJOR BENEFACTORS:
Abbott
Boston Scientific Corporation
Medtronic
BENEFACTORS:
AstraZeneca
ABIOMED, Inc.
Bard Peripheral Vascular, Inc.
Cardiovascular Systems, Inc.
Chiesi USA, Inc.
Cordis, a Cardinal Health Company
Edwards Lifesciences
Getinge Group
Philips IGT-D
Siemens Healthineers
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.
A Revolutionary Approach to the Use of Percutaneous Hemodynamic Support Devices
Thursday, April 6, 2017
8:00 am-2:00 pm
Lunch Program
Hilton Orlando Bonnet Creek
Citrus/Collier/Columbia, Lower Level
7:30 am-8:00 am – Check-in & Breakfast
8:00 am-2:00 pm – Program.
Chair
George W. Vetrovec, MD
VCU Pauley Heart Center
Richmond, VA
Faculty
Mir Babar Basir, DO
Henry Ford Hospital
Detroit, MI
Tony J. DeMartini, MD
Advocate Heart Institute
Springfield, IL
Michael P. Flaherty, MD, PhD
University of Louisville School of Medicine
Louisville, KY
Anthony A. Hilliard, MD
Loma Linda University Medical Center
Loma Linda, CA
Sanjog Kalra, MD
Einstein Health Network
Philadelphia, PA
Amir Kaki, MD
Detroit Medical Center
Detroit, MI
James M. McCabe, MD
University of Washington
Seattle, WA
D. Lynn Morris, MD
Einstein Health Network
Philadelphia, PA
Raj A. Patel, MD
Ochsner Health System
New Orleans, LA
Alexander G. Truesdell, MD
Virginia Heart Inova Heart and Vascular Institute
Fairfax, VA
Agenda
| 8:00 am | Welcome |
Complex PCI with Hemodynamic Support: Identification and Treatment
| 8:05 AM | Identifying the Appropriate Complex Patient for Protected PCI George W. Vetrovec |
| 8:25 AM | Critical Skills for Patient Management: Impella Knowledge, Placement Competency and ICU Management Anthony A. Hilliard |
| 8:45 AM | What is the Appropriate Revascularization Strategy? • Hemodynamic Support Provides a Safe Environment James M. McCabe |
| 9:05 AM | Role of Hemodynamic Support in Complex PCI Sanjog Kalra |
Case Presentations on Protected PCI
| 9:25 AM | CTO Supported PCI Tony J. DeMartini |
| 9:35 AM | UPLM or MVD with Moderately Reduced or Normal EF Raj A. Patel |
| 9:45 AM | Impella as a Strategy to Prevent Acute Kidney Injury (AKI) During HRPCI Michael P. Flaherty |
| 10:00 AM | Break |
Access Techniques: Best Practices
| 10:15 AM | Axillary Insertion of Impella James M. McCabe |
| 10:30 AM | Alternate Access Amir Kaki |
| 10:45 AM | Essential Elements for Establishing a Protected PCI Program
|
Contemporary Look at the Treatment of Cardiogenic Shock
| 11:00 AM | Management of Shock - What is Happening “Under the Hood” When Treating Patients With Pressors, IABP, Impella and ECMO D. Lynn Morris |
| 11:15 AM | Choosing MCS Options in AMI Cardiogenic Shock: Rationale for Impella First Sanjog Kalra |
| 11:30 AM | Door-to-Unloading: A New Quality Metric Alex Truesdell |
| 11:45 AM | Practical Insights for Adding Hemodynamic Support Into Your Critical Care Path: The Detroit Cardiogenic Shock Initiative (CSI) Experience & Outcomes Mir Babar Basir |
| 12:05 PM | Should Every MCS Patient Have a RHC? Alex Truesdell |
Case Presentations on CGS
| 12:25 PM | Percutaneous Support Prior to PCI (A case from Detroit CSI) Amir Kaki |
| 12:40 PM | Right and Left Ventricular Support D. Lynn Morris |
| 1:00 PM | Lunch and Hands-on Workshop |
| 2:00 PM | Adjourn |
Industry Prospectus
Industry Prospectus
Coming Soon.
Exhibitors
The 23rd Annual Interventional Cardiology Fellows Course is sponsored by the Cardiovascular Research Foundation and partially funded through industry supporters.
The support from our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated to educating medical professionals and the public to enhance patient outcomes, helps to make this program possible.
The Cardiovascular Research Foundation gratefully acknowledges:
- Abbott
- Abiomed, Inc.
- ACIST
- Asahi Intecc USA, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Chiesi USA
- Cordis, A Cardinal Health Company
- Corindus Vascular Robotics
- Edwards Lifesciences
- Getinge Group
- Medtronic
- Philips Volcano
- Spectranetics Corporation
